AMERICAN JOURNAL OF PATHOLOGY

Scope & Guideline

Uncovering the Complexities of Disease through Rigorous Research

Introduction

Welcome to your portal for understanding AMERICAN JOURNAL OF PATHOLOGY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0002-9440
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1946 to 2024
AbbreviationAM J PATHOL / Am. J. Pathol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

The American Journal of Pathology (AJP) focuses on advancing the understanding of disease mechanisms through the lens of pathology. It encompasses a wide range of topics, including cellular and molecular biology, disease pathology, and the development of new diagnostic and therapeutic strategies.
  1. Disease Mechanisms and Pathogenesis:
    The journal publishes studies that elucidate the underlying mechanisms of diseases, particularly focusing on cellular and molecular pathways that contribute to pathogenesis.
  2. Diagnostic Pathology:
    AJP emphasizes the development and application of diagnostic methodologies, including histopathology and the use of advanced imaging techniques, to improve disease detection and classification.
  3. Translational Research:
    The journal bridges laboratory research and clinical applications, promoting studies that translate findings from basic science into clinical practice to enhance patient care.
  4. Innovative Therapeutics:
    AJP highlights novel therapeutic strategies, including drug development and genetic interventions, that target specific pathways in disease processes.
  5. Emerging Technologies in Pathology:
    The journal covers advancements in technology, such as artificial intelligence and machine learning, that enhance diagnostic capabilities and improve the understanding of disease progression.
The American Journal of Pathology is witnessing a dynamic shift towards several emerging themes that reflect current trends in biomedical research and societal health challenges.
  1. Artificial Intelligence and Machine Learning:
    The integration of AI and machine learning in pathology is rapidly growing, with an emphasis on automating image analysis and improving diagnostic accuracy.
  2. Microbiome Research:
    There is an increasing focus on the role of the microbiome in various diseases, highlighting its impact on pathogenesis and therapeutic responses, particularly in gastrointestinal and metabolic disorders.
  3. Immunopathology and Inflammation:
    Research exploring the immune response and its role in disease progression, especially in the context of COVID-19 and autoimmune diseases, is gaining prominence.
  4. Targeted Therapies and Personalized Medicine:
    Studies focusing on targeted treatments and personalized medicine approaches are on the rise, reflecting advancements in understanding genetic and molecular disease mechanisms.
  5. Environmental and Lifestyle Factors in Disease:
    Research exploring the impact of environmental exposures, diet, and lifestyle on disease susceptibility and progression is emerging as a significant area of interest.

Declining or Waning

While the American Journal of Pathology continues to explore a broad spectrum of topics, certain areas have seen a decline in focus over recent years, reflecting shifts in research priorities and methodologies.
  1. Traditional Histopathology Techniques:
    There has been a noticeable decrease in publications centered solely on traditional histopathology methods, as the field increasingly incorporates digital pathology and computational techniques.
  2. Basic Histological Studies:
    Research that primarily focuses on basic histological descriptions without integrating modern molecular or genetic insights appears to be waning, as the field moves towards more comprehensive analyses.
  3. Non-Translational Studies:
    Studies that do not connect laboratory findings with clinical implications are less frequently published, indicating a growing emphasis on translational research that directly impacts patient outcomes.
  4. Single Disease Focus:
    There is a trend away from studies that focus exclusively on a single disease entity, as researchers increasingly adopt interdisciplinary approaches that consider multiple diseases or conditions in a broader context.

Similar Journals

Analytical Cellular Pathology

Exploring New Horizons in Cancer and Cell Biology
Publisher: HINDAWI LTDISSN: 2210-7177Frequency:

Analytical Cellular Pathology, published by Hindawi Ltd, is a leading journal in the disciplines of Cancer Research, Cell Biology, and Pathology, and has been dedicated to advancing the field through open access since 1997. Based in Egypt, this journal plays a crucial role in disseminating cutting-edge research and innovative findings, fostering collaboration among researchers and professionals alike. With an impressive array of metrics, including its Q2 ranking in Pathology and Forensic Medicine and notable Scopus rankings, the journal attracts a diverse readership, ensuring significant impact in its categories. Designed to cater to the needs of both emerging and established scholars, Analytical Cellular Pathology promotes accessibility and exchange of knowledge, making it an indispensable resource for those engaged in modern cellular pathology research.

Annual Review of Pathology-Mechanisms of Disease

Transforming Knowledge into Pathological Solutions
Publisher: ANNUAL REVIEWSISSN: 1553-4006Frequency: 1 issue/year

Annual Review of Pathology: Mechanisms of Disease is a premier scholarly journal published by ANNUAL REVIEWS that systematically reviews significant advancements in the field of pathology and the mechanisms underpinning various diseases. With an ISSN of 1553-4006 and an E-ISSN of 1553-4014, the journal has established its importance within the academic community, evidenced by its prestigious Q1 rankings in several categories including medicine, pathology, forensic medicine, and plant science for 2023. Notably, it ranks #1 out of 208 in the pathology and forensic medicine category, placing it in the 99th percentile according to Scopus metrics. Although not an open-access journal, it offers crucial insights to researchers, professionals, and students alike by providing a comprehensive understanding of pathophysiological concepts and emerging trends. The journal continues to be an essential resource for those dedicated to advancing research and practical applications in disease mechanisms.

Pathologia

Empowering Research for a Healthier Tomorrow
Publisher: ZAPORIZHZHYA STATE MEDICAL UNIVISSN: 2306-8027Frequency: 3 issues/year

Pathologia is a prominent open-access journal dedicated to advancing the field of clinical and experimental pathology, published by ZAPORIZHZHYA STATE MEDICAL UNIVERSITY. Established in 2013, the journal aims to provide a platform for researchers, clinicians, and students to share innovative research, case studies, and reviews that are critical to understanding disease mechanisms and improving diagnostic and therapeutic strategies. With a steady commitment to high-quality research dissemination and accessibility, this journal serves as an essential resource for those in the medical and health sciences fields. Researchers engaging with Pathologia can explore a diverse range of topics, including histopathology, molecular pathology, and laboratory medicine, promoting both scholarly discussion and practical applications. The journal's open-access model ensures that vital research findings are freely available to the global academic community, fostering a collaborative environment that is crucial for the advancement of pathology as a discipline.

EXPERIMENTAL AND MOLECULAR PATHOLOGY

Advancing the frontiers of disease understanding.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0014-4800Frequency: 6 issues/year

EXPERIMENTAL AND MOLECULAR PATHOLOGY, a distinguished journal published by Academic Press Inc Elsevier Science, is recognized for its significant contributions to the fields of pathology, clinical biochemistry, and molecular biology. With an ISSN of 0014-4800 and an E-ISSN of 1096-0945, this journal provides a platform for the dissemination of high-quality research articles, reviews, and experimental studies that deepen our understanding of disease mechanisms and diagnostic pathways. Since its inception in 1962 and through its converged publication years, the journal has consistently maintained a solid impact in the academic community, achieving high Scopus rankings—ranked #15 in the field of Pathology and Forensic Medicine and #22 in Clinical Biochemistry, showcasing a commendable percentile standing of 93rd and 81st respectively in 2023. The journal is accessible through various academic libraries and institutional subscriptions, making it an essential resource for researchers, professionals, and students committed to advancing knowledge in these critical areas. With a categorization that includes Q1 rankings in Pathology and Forensic Medicine, EXPERIMENTAL AND MOLECULAR PATHOLOGY stands as a prominent venue for pioneering scientific inquiry and collaborative advancement in molecular diagnostics and therapeutic strategies.

Malaysian Journal of Pathology

Connecting researchers and clinicians through impactful insights.
Publisher: MALAYSIAN JOURNAL PATHOLOGYISSN: 0126-8635Frequency: 3 issues/year

Malaysian Journal of Pathology, published by the MALAYSIAN JOURNAL PATHOLOGY, stands as a pivotal resource in the fields of pathology and medicine, contributing rich insights since its inception in 1979. This peer-reviewed journal, based in Malaysia, is dedicated to disseminating original research, review articles, and case studies that advance the understanding of disease mechanisms and diagnostics. With a current impact factor reflecting its ranked positioning—Q4 in Cell Biology, Q4 in Histology, and Q3 in both Miscellaneous Medicine and Pathology & Forensic Medicine—this journal serves as an essential platform for researchers, clinicians, and students alike. Although it operates without open access, its scholarly rigor and contributions are well recognized, holding ranks such as #84 in Pathology and Forensic Medicine according to Scopus. The Malaysian Journal of Pathology is committed to fostering innovation and excellence in medical research, making it an invaluable tool for professionals seeking to stay abreast of significant advancements in the pathology domain.

VETERINARY CLINICAL PATHOLOGY

Bridging gaps in veterinary science with rigorous scholarship.
Publisher: WILEYISSN: 0275-6382Frequency: 4 issues/year

Veterinary Clinical Pathology, published by Wiley, stands as a crucial resource within the realm of veterinary science, particularly focusing on the intricate field of clinical pathology. Established in 1977, this journal has been at the forefront of advancing knowledge and research, with a converged publication timeline stretching to 2024. With an ISSN of 0275-6382 and an e-ISSN of 1939-165X, it is recognized for its rigorous contributions to the field, achieving a commendable Scopus rank of #87 in General Veterinary, placing it in the 55th percentile among its peers. While it operates under a subscription model, its impact is underscored by its Q2 ranking in the Veterinary category and Q3 in the broader Medicine category for 2023. As a platform for researchers, professionals, and students alike, Veterinary Clinical Pathology aims to disseminate significant findings, foster interdisciplinary collaboration, and enhance the understanding of pathophysiological processes in animals, ultimately contributing to better clinical outcomes and animal health management.

ACTA HISTOCHEMICA

Unveiling the Secrets of Cells with Cutting-Edge Histochemistry
Publisher: ELSEVIER GMBHISSN: 0065-1281Frequency: 8 issues/year

ACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.

ENDOCRINE PATHOLOGY

Shaping the Landscape of Endocrine Pathology
Publisher: HUMANA PRESS INCISSN: 1046-3976Frequency: 4 issues/year

ENDOCRINE PATHOLOGY is a premier journal published by HUMANA PRESS INC, dedicated to advancing the understanding of endocrine disorders through innovative research and clinical practices. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories such as Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine, this journal serves as a pivotal resource for researchers and professionals in the field. The journal covers a broad spectrum of topics related to endocrine pathology, providing insights into mechanisms, diagnostics, and therapeutics that inform both clinical and laboratory practices. Although it does not offer open access, its rigorous peer-review process ensures the dissemination of high-quality, impactful research that shapes clinical strategies and enhances patient care. With distribution spanning from its inception in 1990 to 2024, ENDOCRINE PATHOLOGY stands at the forefront of endocrine research, making it an essential read for anyone involved in the study and treatment of endocrine disorders.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Advancing Knowledge in Experimental Pathology
Publisher: WILEYISSN: 0959-9673Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

MOLECULAR AND CELLULAR PROBES

Advancing Insights into Cellular Mechanisms
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 0890-8508Frequency: 6 issues/year

MOLECULAR AND CELLULAR PROBES, published by Academic Press Ltd - Elsevier Science Ltd, stands as a prominent journal at the intersection of cell and molecular biology. With an ISSN of 0890-8508 and an E-ISSN of 1096-1194, this journal has consistently contributed to the scientific discourse since its inception in 1987, converging its scholarly content through to 2024. As a member of Q3 in both Cell Biology and Molecular Biology categories, it provides a platform for innovative research and critical insights into cellular mechanisms, signaling pathways, and molecular interactions. Its Scopus rankings position it within the top half of its categories, fostering a vibrant academic community that supports the exploration and advancement of biochemistry, genetics, and molecular biology. Although it does not currently offer Open Access, the high-quality peer-reviewed articles published in MOLECULAR AND CELLULAR PROBES are invaluable resources for researchers, professionals, and students who seek to stay at the forefront of breakthroughs in these essential fields.